NCT04361240 2026-02-09
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Abramson Cancer Center at Penn Medicine
Completed
Clinical Trials
30 trialsNCT03787966 2025-11-19
ATOPE
Universidad de Granada
Phase NA Completed
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT05786014 2025-06-12
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
Phase NA Completed
NCT04568161 2025-04-03
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
Phase NA Completed
NCT05403736 2025-02-06
CARMA
Cedars-Sinai Medical Center
Phase NA Completed
NCT04896242 2024-04-04
Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients
Pontificia Universidad Catolica de Chile
Completed
NCT02605512 2023-11-08
BACCARAT
Institut de Radioprotection et de Surete Nucleaire
Phase NA Completed
NCT02881203 2023-07-27
BRAVEHeart
University of Sydney
Phase NA Completed
NCT05960214 2023-07-25
AQUA
Istanbul University
Completed
NCT05927246 2023-07-03
RADAF
Istanbul University
Completed
NCT01719562 2023-05-19
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Wake Forest University Health Sciences
Phase NA Completed
NCT03964142 2023-05-12
ONCORE
Hospital Clinico Universitario de Santiago
Phase NA Completed
NCT00436566 2022-08-05
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
Phase 2 Completed
NCT03940625 2022-05-25
ANKE
Heinrich-Heine University, Duesseldorf
Phase NA Completed
NCT01009918 2021-03-30
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
University of South Florida
Phase 2 Completed
NCT04434404 2020-06-16
Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy
Horus University
Phase 4 Completed
NCT02006979 2019-10-25
Acute Exercise Cardioprotection From Doxorubicin
University of British Columbia
Phase 1 Completed
NCT03235427 2019-05-21
CAROLE
Northwell Health
Completed
NCT02796365 2018-12-13
HF-PROACTIVE
Henry Ford Health System
Phase NA Completed
NCT02423356 2018-08-21
Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin
Indiana University
Completed
NCT01904331 2018-06-15
BLOC
University Medical Center Groningen
Completed
NCT00875238 2018-02-19
PACE in BC
Vanderbilt University Medical Center
Completed
NCT01724450 2018-02-05
Ceccy
University of Sao Paulo
Phase 3 Completed
NCT02065908 2016-12-08
Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer
West Pomeranian Cancer Center
Completed
NCT00002900 2015-10-19
SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
SWOG Cancer Research Network
Completed
NCT00377559 2015-10-06
MYOTAX
Catharina Ziekenhuis Eindhoven
Phase 2 Completed
NCT00968682 2014-12-31
CADY Study ICORG 08-01
Cancer Trials Ireland
Completed
NCT00459771 2014-12-02
Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
The Netherlands Cancer Institute
Phase 3 Completed